MedTech Alliance


The MedTech Alliance program connects OHSU innovators and technologies with investors and external industry to promote commercialization and entrepreneurship. 

In collaboration with Technology Transfer and Business Development and the Oregon Clinical & Translational Research Institute, the goal of this program is to provide additional resources for early-stage biomedical technologies to create realistic commercialization opportunities. 

OHSU hosts meetings 1-2 times per year that are designed to showcase OHSU medical technologies and OHSU startup companies. Technology presentations will be geared towards MedTech Alliance members interested in exploring collaboration and/or licensing opportunities, while startup company presentations will be geared towards members interested in investment opportunities. . 

At any time, MedTech Alliance members can view existing technology opportunities via the TTBD Licensing Opportunities web portal. This portal contains non-confidential summaries of technologies that are at various stages of development. TTBD adds new technologies to this portal regularly as they emerge. Each summary contains details for the TTBD staff member who should be contacted for more information.

Any industry representative or investor interested in OHSU medical technologies and startups should join the MedTech Alliance. This includes, but is not limited to:

  • Business Development specialists at medical device, biotech, or pharmaceutical companies
  • Research & design directors at medical device, biotech, or pharmaceutical companies
  • Angel investors
  • Venture capitalists 
  • Family fund investors
  • Industry scientists
  • Technology Scouts

Participating OHSU technologies and companies have increased exposure to nationally and locally-based industry and investor collaborators, including:

  • Business development specialists at medical device, biotech, or pharmaceutical companies
  • Research & design directors at medical device, biotech, or pharmaceutical companies
  • Angel investors
  • Venture capitalists
  • Family fund investors

Your technologies can benefit from a number of commercialization opportunities, including the examples outlined below.

  • Forming relationships with experienced industry or investment professionals that can offer advice or guidance on the commercialization and/or startup formation process
  • Exposure and marketing for your technology in the broader medical device community
  • Developing an active collaboration with industry partners
    • Sponsored research funding
    • Co-development of a technology
    • Applying jointly for funding (e.g. STTR grant)
  • Licensing agreements
  • Investment in OHSU startup companies

OHSU investigators

For technologies that have been submitted to TTBD using the Technology Disclosure Form, please speak to your assigned technology development manager for more information about sharing your technology with the MedTech Alliance program. Your technology development manager can evaluate your technology for inclusion in this program and review with you the next steps for creating a non-confidential summary.

Industry partners

OHSU's MedTech Alliance program does not have a minimum requirement of participation. Industry and investor members can have varying levels of involvement, including (but not limited to):

  • Attending MedTech Alliance meetings
  • Reviewing technology opportunities and providing feedback
  • Developing an active collaboration 
    • Sponsored research at OHSU
    • Co-development of a technology
    • Applying jointly for funding (e.g. STTR grant)
  • Licensing technology
  • Investing in OHSU startup companies

Past events and presenters

2018 Showcase

Nov. 1, 2018


  1. Luiz Bertassoni, D.D.S., Ph.D.
    BoneMimetic — a biomimetic platform for disease modeling, drug screening, regenerative medicine
  2. Matthew Hansen, M.D., M.C.R. and David Sheridan, M.D.
    Hydrasense: A new novel device for hydration assessment in multiple care settings
  3. Kim Hutchison, M.D.
    Novel mouth sealer to decrease oral leaking and improve compliance with nasal CPAP for the treatment of obstructive sleep apnea (OSA)
  4. Sudarshan Anand, Ph.D.
    Targeting a DNA repair exonuclease to provoke anti-tumor immune responses

2016 Showcase

Sept. 14, 2016


  1. Theodore Hobbs, D.V.M., M.C.R.
    Blood volume determination device
  2. David Spiro, M.D., M.P.H.
    ReelDx, Inc.
  3. Greg Jones, Ph.D., M.B.A.
    First Ascent Biomedical LLC
  4. Xiangshu Xiao, Ph.D.
    Novel lamin-binding ligands for the treatment of triple negative breast cancer 

2015 Fall Showcase

Nov. 4, 2015


  1. Jan van Santen, Ph.D.
    Biospeech, Inc. 
  2. David Huang, M.D., Ph.D.
    Gobiquity Mobile Health, Inc.
  3. Clyde Taylor
    OregonHeart, Inc.
  4. Michael Baker
    Qview Health, Inc. 

2015 Spring Showcase

May 6, 2015


  1. Andrew Chitty, M.B.A. and Dorota Shortell, M.S.M.E.
    Accurate in-home collection of blood samples
  2. Andras Gruber, M.D.
    Antithrombotic drugs without bleeding side effects
  3. Carmem Pfeifer, D.D.S., Ph.D.
    New generation of dental composites
  4. Neil Roundy, M.D. and Rachel Dreilinger
    Bioabsorbable dural clips

2014 Showcase

Nov. 5, 2014


  1. Kim Burchiel, M.D., F.A.C.S.
    Ceremod, Inc.
  2. Paul Cordo, Ph.D.
    AMES Technology, Inc.
  3. David Farrell, Ph.D.
    Gamma Therapeutics, Inc.
  4. Bill Kelly, M.B.A.
    ReelDx, Inc.
  5. Trevor Levin, Ph.D.
    Urology Dx, Inc. 


Contact us at for more information.